Paper Review Records
全部论文审稿周期
11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
98
天
Real-world treatment patterns and survival outcomes in extensive-stage small cell lung cancer across first-line induction and maintenance therapy
作者
Yi-Shao (Justus) Liu; Parth A Desai; Humera Khurshid; Anne C Chiang; Christine L Hann; Melissa L Johnson; Erik S Anderson; Rani Najdi; Jessie Wang; Xerxes Pundole展开收起
作者单位
1. Amgen Inc, Thousand Oaks, CA 91320, United States; 2. Department of Hematology & Medical Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA 19140, United States; 3. Brown University School of Medicine-Rhode Island Hospital, Providence, RI 02903, United States; 4. Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, United States; 5. Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21287, United States; 6. Sarah Cannon Research Institute, Nashville, TN 37203, United States展开收起
92
天
Durable response to vebreltinib in heavily pretreated MET-amplified intrahepatic cholangiocarcinoma: a case report
作者
Yingying Hang; Lu Bai; Hsiquan Hsu; Ying Chen; Fufeng Wang; Wuyan Xu; Xia Zhen; Zihao Wang; Yuan Li; Jun Qian展开收起
作者单位
1. Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Chinese Medicine, Nanjing 210029, China; 2. The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China; 3. Jiangsu Collaborative Innovation Center of TCM Cancer Prevention and Treatment, Nanjing 210023, China; 4. Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing 210032, China; 5. Department of Pathology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China展开收起
412
天
Immune checkpoint inhibitors induced autoimmune hemolytic anemia in patients with malignant cancer
作者
Aoxi Liang; Yuanqiang Wu; Shengchi Chen; Jisheng Li; Yue Pan; Yixing Luo; Yue Zeng; Shijiao Yao; Shuxing Wang; Chunhong Hu; Xianling Liu; Fang Wu展开收起
作者单位
1. Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China; 2. Department of Oncology, Nanping First Hospital Affiliated to Fujian Medical University, Nanping 353000, China; 3. Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan 250012, China; 4. Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China; 5. Department of Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China; 6. Xiangya School of Medicine, Central South University, Changsha 410013, China; 7. Hunan Cancer Mega-Data Intelligent Application and Engineering Research Centre, Changsha 410011, China; 8. Department of Oncology, Guilin Hospital of the Second Xiangya Hospital, Central South University, Guilin 541100, China; 9. Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, China; 10. Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, The Second Xiangya Hospital, Central South University, Changsha 410011, China; 11. FuRong Laboratory, Changsha 410078, China; 12. Changsha Thoracic Cancer Prevention and Treatment Technology Innovation Center, Changsha 410011, China展开收起
173
天
Treatment of metastatic solid pseudopapillary neoplasms
作者
Courtney Porfido; Diane Reidy-Lagunes; Nitya Raj展开收起
作者单位
1. Department of Gastrointestinal Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States; 2. Division of Medical Oncology, Duke Cancer Institute, Durham, NC 27710, United States展开收起
79
天
Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation
作者
Galip Can Uyar; Kadriye Başkurt; Orhun Akdoğan; Enes Yeşilbaş; Mustafa Ersoy; Tuba Uğur Tuzcu; Kadriye Bir Yücel; Mustafa Altınbaş; Ömür Berna Çakmak Öksüzoğlu; Gökşen İnanç İmamoğlu; Osman Sütcüoğlu展开收起
作者单位
1. Department of Medical Oncology, Etlik City Hospital, Ankara, 06170, Turkey; 2. Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, 06500, Turkey; 3. Department of Medical Oncology, Kütahya City Hospital, Kütahya, 43100, Turkey展开收起
263
天
New prognosis indexes specific to Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma combining functional hepatic reserve and tumor burden
作者
Koji Fujita; Rie Yano; Mai Nakahara; Kyoko Oura; Hironobu Suto; Asahiro Morishita; Takashi Himoto; Keiichi Okano; Hideki Kobara展开收起
作者单位
1. Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu 760-8521, Japan; 2. Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Takamatsu 760-8521, Japan; 3. Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu 761-0123, Japan展开收起
FAQ
ONCOLOGIST审稿要多久?
截至2026-11-19,CrushSCI 收录了 ONCOLOGIST 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 53 天(Symptom clusters and quality of life among patients with thyroid cancer during early survivorship: a national multicenter cross-sectional study,2026-06-05 收稿,2026-07-28 录用),最慢一篇用了 412 天;平均 136.1 天,中位数 92 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
